Biote (BTMD) Change in Accured Expenses (2021 - 2026)

Biote's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at $256000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 109.61% year-over-year to $256000.0; the TTM figure through Mar 2026 stood at $178000.0 (down 94.34% YoY), while the FY2025 annual figure was -$2.7 million, down 159.22% from the prior year.
• Change in Accured Expenses was $256000.0 for Q1 2026 at Biote, up from -$1.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $4.9 million in Q3 2023 to a low of -$26.1 million in Q2 2022.
• Historically, Change in Accured Expenses has averaged -$1.6 million across 5 years, with a median of -$826000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses plunged 32986.68% in 2022, then soared 358.59% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $555000.0 in 2022, then slumped by 421.08% to -$1.8 million in 2023, then jumped by 358.59% to $4.6 million in 2024, then tumbled by 127.6% to -$1.3 million in 2025, then jumped by 120.13% to $256000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $256000.0 (Q1 2026), -$1.3 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.